Drug Type Autologous CAR-T |
Synonyms Autoimmune(Appia Bio) |
Target- |
Mechanism Immunologic cytotoxicity |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Appia Bio, Inc.Startup |
Active Organization Appia Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | Appia Bio, Inc.Startup | 16 Apr 2024 |
Multiple Myeloma | Discovery | US | Appia Bio, Inc.Startup | 16 Apr 2024 |